<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-SLE-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Sierra Leone (la): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Sierra Leone: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="FR">Cette activit&#xE9; d&#xE9;taille notre travail sur le Aide cibl&#xE9;e aux pays en Sierra Leone (la), gr&#xE2;ce &#xE0; la mise &#xE0; disposition des donn&#xE9;es budg&#xE9;taires et des transactions. Nous fournissons &#xE9;galement les documents pertinents qui guident ces activit&#xE9;s que sont les formulaires de demande de soutien fournis par le gouvernement de Sierra Leone (la) ainsi que les lettres de d&#xE9;cisions &#xE9;mises par Gavi, pour progresser. Ces documents d&#xE9;crivent les activit&#xE9;s, les objectifs ainsi que les b&#xE9;n&#xE9;ficiaires.</narrative>
   <narrative xml:lang="EN">This activity details our work on Targeted country assistance in Sierra Leone through the provision of budget and transaction data.  We also provide the relevant documents that guide these activities, which are the support request proposal(s) provided by the Government of Sierra Leone, as well as the decision letter(s) issued by Gavi, for progress.  These documents describe the activities, the objectives as well as the beneficiaries.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org ref="US-EIN-27-1414646" role="4" type="21">
   <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="US-EIN-84-0399006" role="4" type="21">
   <narrative xml:lang="EN">The Aspen Institute</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Sierra Leone</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="SL" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="SL" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Freetown</narrative>
   </name>
   <administrative code="SL" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>8.484 -13.22994</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">1179642</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">1735833</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">1289449</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">312693.14</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-29">312693.14</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="SLEPEF-TCA-ASPEN2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">201816</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">28000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">149333</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-CHAI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">274421</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">386014</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">132216</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-ASPEN2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">288307</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-CHAI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">604538</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-KIGOZI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">6600</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-KIGOZI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">39644</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">488074</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">308670</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-CHAI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">488814</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-ICAP2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">124000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-ICAP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-KIGOZI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">8660</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-KIGOZI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">68088</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">383854</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">216033</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="SLEPEF-TCA-CHAI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">48651</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001168">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-135143</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000223">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">288307</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-288307</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">288307</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ASPEN (The Aspen Institute)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-84-0399006" type="21">
    <narrative xml:lang="EN">The Aspen Institute</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000870">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">28000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000871">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">149333</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900003830">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">81777</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001199">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000238">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">177311</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002738">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-06"></transaction-date>
   <value currency="USD" value-date="2020-07-06">195374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004767">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-24"></transaction-date>
   <value currency="USD" value-date="2020-11-24">40775</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-177311</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">177311</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005168">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">169570</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-15713</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-2905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">15713</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000009">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">2905</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000086">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">2890</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001469">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001410">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-31"></transaction-date>
   <value currency="USD" value-date="2021-03-31">13323</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001976">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-10"></transaction-date>
   <value currency="USD" value-date="2021-05-10">26647</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004503">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-21"></transaction-date>
   <value currency="USD" value-date="2021-09-21">62420</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005006">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-06"></transaction-date>
   <value currency="USD" value-date="2021-10-06">22321</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004987">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-11"></transaction-date>
   <value currency="USD" value-date="2021-10-11">20910</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005149">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-15"></transaction-date>
   <value currency="USD" value-date="2021-11-15">27712</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004296">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">179325</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004296">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">4038</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005362">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">47</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-02"></transaction-date>
   <value currency="USD" value-date="2021-12-02">66962</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">-4038</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">4038</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHAI (Clinton Health Access Initiative)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="US-EIN-27-1414646" type="21">
    <narrative xml:lang="EN">Clinton Health Access Initiative</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004198">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-06"></transaction-date>
   <value currency="USD" value-date="2021-09-06">7930</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ICAP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006419">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-25"></transaction-date>
   <value currency="USD" value-date="2021-11-25">16569</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ICAP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006196">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">7930</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ICAP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007340">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">11394</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-ICAP</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005640">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">5600</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-KIGOZI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">733</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-20088</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">20088</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">1538</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">225</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">281</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">413</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000872">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">386014</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">386014</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">102060</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-13"></transaction-date>
   <value currency="USD" value-date="2021-07-13">383854</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000873">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">132216</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">159940</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">148730</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-20"></transaction-date>
   <value currency="USD" value-date="2021-07-20">216033</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-sierra-leone-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Sierra Leone 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-sierra-leone-2017">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Sierra Leone 2017</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-sierra-leone-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Sierra Leone 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-sierra-leone-2018">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Sierra Leone 2018</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-sierra-leone-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Sierra Leone 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-sierra-leone-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Sierra Leone 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-sierra-leone-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Sierra Leone 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-sierra-leone-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Sierra Leone 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-07-27"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <related-activity ref="47122-SLE" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Management review and response system established in 4 new districts with relevant and timely monthly data being provided from and to PHUs to inform data and delivery improvements.
 
2. Mobile device for data entry needs assessment and feasibility study completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support on data strengthening activities with focus on increasing quality, accuracy, and completeness of information from all levels:
1) Targeted improvements to improve access to data for key performance indicators
2) Conduct and identify improvements in routine data analysis including support on the coordination of the NLTWG and quarterly M&amp;E meeting
3) Implement management review and response system at 4 additional districts
4) Assess suitability and develop strategic plans for further integration with existing MoHS technology solutions">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support on data strengthening activities with focus on increasing quality, accuracy, and completeness of information from all levels:
1) Targeted improvements to improve access to data for key performance indicators
2) Conduct and identify improvements in routine data analysis including support on the coordination of the NLTWG and quarterly M&amp;E meeting
3) Implement management review and response system at 4 additional districts
4) Assess suitability and develop strategic plans for further integration with existing MoHS technology solutions">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Implemented a routine system of supply data use in vaccine allocation planning and/or other target supply chain processes at central and district level. 
2. Response systems supported to ensure that supply chain data is used to improve outcomes at district and PHU level.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support program to make use of data on stock and wastages to identify necessary improvements in supply chain performance and key processes (e.g., vaccine stock allocation to districts and PHUs), reinforcing use of data for decision making">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support program to make use of data on stock and wastages to identify necessary improvements in supply chain performance and key processes (e.g., vaccine stock allocation to districts and PHUs), reinforcing use of data for decision making">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Commence management review and response system implementation in 4 new districts with DMOs, DOOs, M&amp;E and DIOs fully engaged. 

2. In each of the 4 districts selected by the Parties, triangulation of the following data sets :immunization, antenatal visits, surveillance, RRIV / supply and regular monthly assessment of their completeness and data quality checks implemented quarterly  and tracked over time. 

3. Management review and response system implementation commenced in 4 new districts with DMOs, DOOs and DIOs fully engaged.  

4. Tool, system and process improvements for data entry identified, documented, proposed and supported (HMIS, LMIS in selected 4 districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of &quot;Data Review and Response System&quot; and Capacity Building of EPI and district teams in phased manner in 4 new districts selected by the Government, including: 
 
1.	Support EPI, district teams/facility-in-charges/EPI focal persons in select districts for making use of Stock Ledgers/Stock Requisition and DHIS2 RRIV data for improvements in data reporting, quality, and vaccine stocks through monthly review and follow ups

2.	Development of Data Quality Audit (DQA) Tools and perform Data Quality Audits (Quarterly) at sampled health facilities in select districts to improve the quality and reliability of data reported in DHIS2 (e-HMIS). 


 3. Capacity building/training of District Operations Officer (DOO) 1 &amp; 2 from districts on DHIS2 Dashboard (HF2/RRIV) and Data Audits for Data Review and Response System

 4. Targeted training on data reporting and improving data quality of EPI Focals (up to 50% of facilities in selected 4districts) who are deemed most in need of the training to improve reporting and quality 

 5. Support with the use of new facility-level open and closed vial wastage data (RRIV) to help forecast next years supply needs">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Management review and response system established in 4 new districts with relevant and timely monthly data being provided from and to PHUs to inform data and delivery improvements.
 
2. Mobile device for data entry needs assessment and feasibility study completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support on data strengthening activities with focus on increasing quality, accuracy, and completeness of information from all levels:
1) Targeted improvements to improve access to data for key performance indicators
2) Conduct and identify improvements in routine data analysis including support on the coordination of the NLTWG and quarterly M&amp;E meeting
3) Implement management review and response system at 4 additional districts
4) Assess suitability and develop strategic plans for further integration with existing MoHS technology solutions">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Full utilization of the ?COVID-19 routine immunization tracker? by program to monitor RI trends at National and District-levels

2. Monthly PHU/Hospital-level analysis covering all health facilities across districts where RI services are offered under EPI. 
. of trends in routine immunization levels and reporting rates available in the tracker per antigen type.

3. Report submitted to the EPI and Gavi Programme with recommendations on which Districts and Health Facilities could be prioritized in future catch-up campaigns based on data analysis of COVID-19 impact on routine immunizations vs. historical trends, enabled by the use of the tracker.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Supporting &quot;data for decision-making&quot; in deciding which districts, chiefdoms and facilities are to be prioritized or de-prioritized for catch-up/intensification of RI activities based on impact tracking of COVID-19 using DHIS2 data. The use of tracker by EPI to continue until the administration of Covid19 vaccine is completed.">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Provide training and handover of ?the tracker? to EPI M&amp;E Team by December 2020.

2. Support EPI to update ?the tracker? for continued use in 2021 (by February if required).</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support COVID response: 
1)	Technical assistance in development of tools to determine Covid19 impact on routine immunization activities
2)	Technical support in spotting RI challenges till the level of PHUs posed by Covid19 pandemic
3)	Support in development of Covid19 RI recovery plan 
4)	Support in national performance and progress review of the RI activities including Covid19 impact
5)	Support in deployment and usage of technology solution for rapid assessment and dissemination of lessons learnt during catch up campaigns">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support COVID response: 
1)	Technical assistance in development of tools to determine Covid19 impact on routine immunization activities
2)	Technical support in spotting RI challenges till the level of PHUs posed by Covid19 pandemic
3)	Support in development of Covid19 RI recovery plan 
4)	Support in national performance and progress review of the RI activities including Covid19 impact
5)	Support in deployment and usage of technology solution for rapid assessment and dissemination of lessons learnt during catch up campaigns">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">70% Sentinel surveillance and case based data on VPDs generated and shared timely</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support sentinel surveillance for new vaccines (Rota, PBM, Influenza) and Measles as well as support conduct of quarterly program review meetings">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of districts trained on EPI app integrated into DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Training of district health teams on on utilization of the EPI app integrated with DHIS2 training : 4 participants per district">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Survey protocol/concept note for conduct of cEPI review in 16 districts developed and localimplementing partner identified.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conducting comprehensive EPI review">
      <location ref="SL"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Established functional NITAG  as measured by standard criteria</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support strengthening of the National Immunization Program management by a) Facilitating development of National Immunization operations Plan and review of cMYP through consultative workshops ,  b) Capacity building on Mid-level managers (MLM), c) supporting establishment of NITAG and functioning of ICC through orientation of members, facilitating biannual NITAG and ICC meetings and monitoring of recommendations; d) Facilitating indepth national immunization review meetings and tracking of action points,">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support strengthening of the National Immunization Program management by a) Facilitating development of National Immunization operations Plan and review of cMYP through consultative workshops ,  b) Capacity building on Mid-level managers (MLM), c) supporting establishment of NITAG and functioning of ICC through orientation of members, facilitating biannual NITAG and ICC meetings and monitoring of recommendations; d) Facilitating indepth national immunization review meetings and tracking of action points,">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Program plan updated to reflected feedback from stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support around planning of interventions to improve coverage/uptake/demand and address equity issues in low performing districts in Sierra Leone based on data generated from CDC&apos;s ongoing mixed-methods Urban Needs Assessment and GAVI/EPI KAP survey being planned together with UNICEF and partners">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV introduced into all districts, evidenced in campaign report</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning implementation and monitoring of new vaccine introduction - support vaccine, cold chain management and logistics related to HPV introduction in routine immunization. Support proposal development for HepB birth dose introduction">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Orders for HPV vaccine placed and cold chain rapid assessment conducted in preparation of the HPV introduction</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning, implementation and monitoring of new vaccine introduction - including rapid assessment for cold chain readiness and effective supply management for the introduction of HPV.">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Government endorsed multi-year transition plan for increased immunization financing</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Propose solutions to identified challenges at the budget development and execution stages for vaccine procurement; 2) Develop a multi-year forecast for vaccine procurement (incl. co-financing of EPI supplies); 3) Support the goverment in the development of a multi-year transition plan to gradually take over the funding for procurement of traditional vaccines; 4) High-level advocacy / development of the advocacy messages for increased domestic resources for EPI">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Propose solutions to identified challenges at the budget development and execution stages for vaccine procurement; 2) Develop a multi-year forecast for vaccine procurement (incl. co-financing of EPI supplies); 3) Support the goverment in the development of a multi-year transition plan to gradually take over the funding for procurement of traditional vaccines; 4) High-level advocacy / development of the advocacy messages for increased domestic resources for EPI">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Propose solutions to identified challenges at the budget development and execution stages for vaccine procurement; 2) Develop a multi-year forecast for vaccine procurement (incl. co-financing of EPI supplies); 3) Support the goverment in the development of a multi-year transition plan to gradually take over the funding for procurement of traditional vaccines; 4) High-level advocacy / development of the advocacy messages for increased domestic resources for EPI">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A multi-year forecast for EPI financing with transition plan developed with government engagement</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Propose solutions to identified challenges at the budget development and execution stages for vaccine procurement; 2) Develop a multi-year forecast for vaccine procurement (incl. co-financing of EPI supplies); 3) Support the goverment in the development of a multi-year transition plan to gradually take over the funding for procurement of traditional vaccines; 4) High-level advocacy / development of the advocacy messages for increased domestic resources for EPI">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NIS developed and endorsed by ICC by the end of Q4 2021.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Development of national immunization strategy to guide the program in the next five years">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV PIE report with lessons learnt and recommendations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct post HPV introduction evaluation">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct post HPV introduction evaluation">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduct post HPV introduction evaluation">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Post HPV introduction evaluation field work with data collation/validation completed in 16 Districts by the end of Q4 2021.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Post-HPV introduction evaluation particualy given the fact that national scale up is done in context of COVID-19">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Attained &gt;90% level of readiness for HPV introduction at national and district level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support country to introduce HPV in 2021 through a) technical support to adapt guides, tools and monitoring readiness, b)Stakeholder sensitization workshop to creat awareness on multi-pronged approach towards cervical cancer, c) deployment of 1-2 national TAs for focused support to high priotiy districts">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support country to introduce HPV in 2020 through a) technical support to adapt guides, tools and monitoring readiness, b)Stakeholder sensitization workshop to creat awareness on multi-pronged approach towards cervical cancer, c) deployment of 1-2 national TAs for focused support to high priotiy districts">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support country to introduce HPV in 2020 through a) technical support to adapt guides, tools and monitoring readiness, b)Stakeholder sensitization workshop to creat awareness on multi-pronged approach towards cervical cancer, c) deployment of 1-2 national TAs for focused support to high priotiy districts">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI Policy guide updated and disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Updating of guidelines and policies, a) Immunisation in Practice (IIP) guideline, b) EPI policy guide review , finalisation and dissemination">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Updating of guidelines and policies, a) Immunisation in Practice (IIP) guideline, b) EPI policy guide review , finalisation and dissemination">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Updating of guidelines and policies, a) Immunisation in Practice (IIP) guideline, b) EPI policy guide review , finalisation and dissemination">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation of Measles laboratory processes and SOPs completed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Assessment exercise on the Central Public Health Reference Laboratory for full accreditation for Measles laboratory investigations.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ODK-based digital supervisory checklist/v customized to accomodated 100% of CH/EPI identified priority issues.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Revision of supervision questionnaire and training on ODK">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV guidelines and training materials developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support country to introduce HPV in 2021 through a) technical support to adapt guides, tools and monitoring readiness, b)Stakeholder sensitization workshop to creat awareness on multi-pronged approach towards cervical cancer, c) deployment of 1-2 national TAs for focused support to high priotiy districts">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Phase 2 Covax, RI catch up activities and IPV vaccination implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning, implementation, supervision and monitoring of inttrroduction of new vaccines (nOPV2, Covax, IPV, HPV), including RI catch-up activities and Vaccine Preventable Disease Outbreak responses (OBR). To include conduct of readiness assessments as applicable, development and validation of training guidelines and data tools, support coordination and conduct of. trainings, independent monitoring and evaluation activities, etc.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">cVDPV2 Outbreak Response and phase 1 Covax introduction done</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning, implementation, supervision and monitoring of inttrroduction of new vaccines (nOPV2, Covax, IPV, HPV), including RI catch-up activities and Vaccine Preventable Disease Outbreak responses (OBR). To include conduct of readiness assessments as applicable, development and validation of training guidelines and data tools, support coordination and conduct of. trainings, independent monitoring and evaluation activities, etc.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) IPC modules to improve communication between service providers and care takers. 2) Concept note for male involvement strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Provide support to the implementation of an HPV communication plan with focus on strengthening inter-personal communication (IPC) of service providers. 2) Build a model for male involvement for promotion of EPI services by pilot testing the intervention in WAR">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">HPV introduced in all districts with not less than 80% coverage of target group (14 year age cohort)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning implementation and monitoring of new vaccine introduction - support vaccine, cold chain management and logistics related to MR SIAs and introduction of MR and HPV in routine immunization.">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Report on mapping of vaccine procurement budgeting process available.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Propose solutions to identified challenges at the budget development and execution stages for vaccine procurement; 2) Develop a multi-year forecast for vaccine procurement (incl. co-financing of EPI supplies); 3) Support the goverment in the development of a multi-year transition plan to gradually take over the funding for procurement of traditional vaccines; 4) High-level advocacy / development of the advocacy messages for increased domestic resources for EPI">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Vaccine orders informed by accurate vaccine quantification; 2. Report on cold chain assessment in preparation for HPV introduction</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning implementation and monitoring of new vaccine introduction - support vaccine, cold chain management and logistics related to HPV introduction in routine immunization. Support proposal development for HepB birth dose introduction">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Geo mapping report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In-depth analysis on cold chain optimization options for improved supply chain management (geo-mapping of facilities vs population size, access, etc.) as a follow-up to Supply Chain System Design work">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 25% of the PHUs submit vaccine and device stock balance data using Rapidpro technology</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the roll out of Rapidpro technology innovation for collection of monthly vaccine stock data at PHUs for increased vaccine visibility, especially on vaccine wastage and utilization.">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Two quarterly physical stock takes conducted by end of November 2021 at national and district levels. 
2. At least 80% districts reporting monthly on SMT ensuring visibility for vaccine managment and informed decisions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Data for management and decision 
1. Continue to support effective use of Stock Management Tool and other vaccine management tools for improved vaccine management practices. 
2. Support monitoring of vaccine stock by quarterly physical stock take at national level. 
3. Support decentralized use of SMT to the districts including IRP. 
4. Support to ensure quarterly cold chain inventory update from all districts. 
5. Explore feasibility of integrating cold chain equipment into computerised maintenance management system (CMMS) currently under pilot testing)
6. To have summarized CCE data on a quarterly basis by districts">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical support provided for the training of 100 EPI stafff at national and district levels on immunization data management and quality improvement.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="A local TA to support capacity building for EPI Teams at National and District levels, including: 
? support implementation of Urban Immunization activities to address identified  root causes of poor urban vaccnation coverage;
? Integration with other departments in reaching children in pre-schools (cr&#xE8;ches and day cares) through active engagements with other stakeholders and proprietors. 
?  support innovative and tailored strategies for coverage and equity including the reduction of zero doses;">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Intervention results available and shared with stakeholders to document (i) feasibility (ii) effectiveness in terms of EPI outcomes for reducing dropout (iii) demonstration of skills transfer and capacity strengthening among EPI staff</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Building in-country capacity among EPI staff on how to undertake an integrated model for defaulter-tracking using existing community health workers linked with PHU-level EPI staff during community outreach / demand promotion sessions in two priority districts identified by the EPI programme. In addition, support skills transfer in capturing high quality data needed to demonstrate effectiveness of the integrated-model on identification of defaulters and reduction of drop-out (Penta1-Penta3; MCV1-MCV2;).">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Cold chain optimization recommendation report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In-depth analysis on cold chain optimization options for improved supply chain management (geo-mapping of facilities vs population size, access, etc.) as a follow-up to Supply Chain System Design work">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Cold Chain technicas trained 2. Submission of monthly report documenting that Cold Chain Technicians performed routine tasks; 3. Monthly temperature review reports available;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Cold Chain and Logistics managment (1) Support EPI team in conducting routine preventive maintenance of the new cold store; 2) Build capacity of cold chain technicians at national level on cold room maintenance and repair; 3) Establish temperature monitoring system across the country through effective use of RTMD and Fridge Tags; 4) Support to strengthen preventive maintenance system of cold chain equipment; 5) Develop standardized guidelines on the procurement and decomissioning of cold chain equipment) 6) Support cold room operations">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVM self-assessment reports with improvement plans from 70% of the districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EVM self assessment at all levels of the country immunization supply chain system including the national cold store, 14 district store and selected PHUs in all districts">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support EVM self assessment at all levels of the country immunization supply chain system including the national cold store, 14 district store and selected PHUs in all districts">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.	High quality HPV introduction take place, with appropriate coordination of all stakeholders&apos; roles/responsibilities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide support on coordination and accountability of HPV introduction including support on:
1) HPV TWG and coordination on non immunisation platforms 
2) planning for HPV SC requirements 
3) progress review 
4) Microplanning best practice and quality assurance 
5) coordination with lower levels on responsibilities, 
6) EPI efforts on training and IEC, 
7) AEFI guidance, 
8) monitoring practices
9) Development of rapid assessment tool post 1st and 2nd dose administration)">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide support on coordination and accountability of HPV introduction including support on:
1) HPV TWG and coordination on non immunisation platforms 
2) planning for HPV SC requirements 
3) progress review 
4) Microplanning best practice and quality assurance 
5) coordination with lower levels on responsibilities, 
6) EPI efforts on training and IEC, 
7) AEFI guidance, 
8) monitoring practices
9) Development of rapid assessment tool post 1st and 2nd dose administration)">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. HPV introduction takes place, with appropriate coordination of all stakeholders&apos; roles/responsibilities. A transition report enclosing information on work plan, tools development, microplanning, training, IEC communication and disbursement (if any), will be generated and handed over to EPI by Dec?21.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide support (up to 1st dose introduction) on coordination and accountability of HPV introduction including support on:
 1) HPV TWG and coordination on non-immunisation platforms 
 2) planning for HPV SC requirements 
 3) progress review 
 4) Microplanning best practice and quality assurance 
 5) coordination with lower levels on responsibilities, 
 6) EPI efforts on training and IEC, 
7) monitoring practices
 8) rapid assessment post-implementation (first dose)
 9) coordination on preparation and implementation of second dose">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. High quality HPV introduction take place, with appropriate coordination of all stakeholders&apos; roles/responsibilities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide support on coordination and accountability of HPV introduction including support on: 1) HPV TWG and coordination on non immunisation platforms 2) planning for HPV SC requirements 3) progress review 4) Microplanning best practice and quality assurance 5) coordination with lower levels on responsibilities, 6) EPI efforts on training and IEC, 7) AEFI guidance, 8) monitoring practices 9) Development of rapid assessment tool post 1st and 2nd dose administration)">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 80% of visited facilities are making proper use of RED Monitoring Chart</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Revise and print RED Monitoring chart and monitor its use">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Revise and print RED Monitoring chart and monitor its use">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Monthly submission of SMT reports from National level. Monthly submission of SMT reports from at least 75% districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Data for management and decision (1) Support vaccine supply planning and strengthening of regular SMT update and use, 2) Support monitoring of vaccine stock by quarterly physical stock take at national level. 3) Support decentralized use of SMT to the districts including IRP. 4) support to ensure quarterly cold chain inventory update from all districts.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support Data for management and decision (1) Support vaccine supply planning and strengthening of regular SMT update and use, 2) Support monitoring of vaccine stock by quarterly physical stock take at national level. 3) Support decentralized use of SMT to the districts including IRP. 4) support to ensure quarterly cold chain inventory update from all districts.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 50 newly procured SSDs are properly installed in selected facilities
  2. Quarterly cold chain reports received on time from at least 8/16 districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support cold chain and logistics management:
  1. Support EPI team in conducting routine preventive maintenance of the new cold stores
  2. Support the installation of new CCE and provide routine preventive maintenanceof CCEOPs and the cold rooms
  3. Continue to support temperature monitoring system across the country through effective use of RTMDs and fridge tags">
      <location ref="SL"></location>
     </target>
     <actual value="Completed">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ToR for the consultancy developed and finalised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support cold chain assessment to inform cMYP development">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ToR for the consultancy developed and finalised. Customized assessment tool developed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the conduct of external Effective Vaccine Management Assessment at all levels of the country immunization supply chain system with costed improvement plans.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assessment report of male involvement model implementation in WAR for future scaling up</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Provide support to the implementation of an HPV communication plan with focus on strengthening inter-personal communication (IPC) of service providers. 2) Build a model for male involvement for promotion of EPI services by pilot testing the intervention in WAR">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Provide support to the implementation of an HPV communication plan with focus on strengthening inter-personal communication (IPC) of service providers. 2) Build a model for male involvement for promotion of EPI services by pilot testing the intervention in WAR">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Provide support to the implementation of an HPV communication plan with focus on strengthening inter-personal communication (IPC) of service providers. 2) Build a model for male involvement for promotion of EPI services by pilot testing the intervention in WAR">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training report documenting that 100% of the District Social Mobilization cordinators and service providers trained on the IPC module as part of HPV introduction training</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1) Provide support to the implementation of an HPV communication plan with focus on strengthening inter-personal communication (IPC) of service providers. 2) Build a model for male involvement for promotion of EPI services by pilot testing the intervention in WAR">
      <location ref="SL"></location>
     </target>
     <actual value="Major Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Updated CHW training curriculum and regisiters that incorporate enhanced immunization promotion and defaulter tracing activities (including identification of zero dose children) and reporting</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical assistance to maximize the community health workers (CHWs) contribution to the improved uptake of immunization services through sensitisation, defaulter tracing (including identification of zero dose children) with enhanced linkage between CHWs and PHUs">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Five year financing plan presented to ICC and MOHS Leadership for endorsement</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support High-level advocacy for increased domestic resources for EPI for procurement and co-financing of traditional and new vaccines respectively.">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Updated IPC training modules (to integrate risk com and rumours/misperception management) and updated messages on immunization, based on communication needs surrounding introduction of new vaccines in country (NoPV2, COVAX, HPV); 

2) Design of IEC and media materials

3) Mapping of feedback mechanisms for rumours and misinformation tracking and management (online and offline social platforms)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support communication social mobilization efforts as part of the operationalization of the immunization communication strategy, to build population awareness, trust and uptake of routine vaccination through 1) design and production of standard IEC materials for health facilities and social mobilizers, including media materials (jingles) and 2) technical asistance to strenghten mechanisms for monitoring and management of rumours and misperceptions">
      <location ref="SL"></location>
     </target>
     <actual value="On Track">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="SL"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="SL"></location>
     </target>
     <actual>
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="SL"></location>
     </target>
     <actual>
      <location ref="SL"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
